ENTITY
Alphamab Co Ltd

Alphamab Co Ltd (9966 HK)

103
Analysis
Health CareChina
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
bullishAlphamab Co Ltd
08 Dec 2019 13:19

ECM Weekly (8 Dec 2019) - OneConnect, JS Global, Renrui, Poly Property, Freee, Burger King India

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This...

Share
bullishAlphamab Co Ltd
03 Dec 2019 01:53

Alphamab Oncology IPO: Valuation Easy to Swallow

Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
534 Views
Share
bullishVenus MedTech
01 Dec 2019 11:18

ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...

Share
bullishAlphamab Co Ltd
29 Nov 2019 14:00

Alphamab (康宁杰瑞) IPO: You Will Likely Be Zeroed

Alphamab launched book building to raise up to USD 234 million to list in Hong Kong.  In our previous notes, we covered the company’s key pipeline...

Logo
567 Views
Share
bullishAlphamab Co Ltd
28 Nov 2019 16:23

Alphamab Oncology IPO Initiation: Clear Diagnosis

Alphamab Co Ltd (1728643D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
484 Views
Share
x